- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological treatment of diabetes in older people
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 16, Issue 12, Pages 1192-1203
Publisher
Wiley
Online
2014-07-30
DOI
10.1111/dom.12362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Developments in Diabetes Management: Medications of the 21st Century
- (2014) Vivian A. Fonseca CLINICAL THERAPEUTICS
- Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better?
- (2014) Yuanhui Zhang et al. DIABETES CARE
- Use of Antidiabetic Drugs in the U.S., 2003–2012
- (2014) Christian Hampp et al. DIABETES CARE
- Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes
- (2014) A. Avogaro et al. DIABETES OBESITY & METABOLISM
- Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice
- (2014) P. Rossetti et al. DIABETES OBESITY & METABOLISM
- Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes: A Pooled Analysis of 25 Clinical Studies
- (2014) Elizabeth M. Round et al. DRUGS & AGING
- Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis
- (2014) Hongzhu Li et al. EXPERIMENTAL CELL RESEARCH
- Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial
- (2014) Arijit Ghosh et al. INDIAN JOURNAL OF PHARMACOLOGY
- Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
- (2013) Faramarz Ismail-Beigi et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)
- (2013) Bo Ahrén et al. DIABETES CARE
- Economic Costs of Diabetes in the U.S. in 2012
- (2013) DIABETES CARE
- Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study
- (2013) J. Rosenstock et al. DIABETES OBESITY & METABOLISM
- Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus
- (2013) L. H. Chen et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
- (2013) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- Sulfonylureas and Risk of Falls and Fractures: A Systematic Review
- (2013) Kate L. Lapane et al. DRUGS & AGING
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
- (2013) Andrew Grey et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study
- (2013) Anna Solini et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Guidelines Abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 Update
- (2013) JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
- (2013) W David Strain et al. LANCET
- Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
- (2013) Anthony H Barnett et al. LANCET
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
- (2013) William T Cefalu et al. LANCET
- Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
- (2013) C. Bosetti et al. ONCOLOGIST
- Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
- (2013) Carl V. Asche et al. PHARMACOECONOMICS
- Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus
- (2013) Molly G. Minze et al. PHARMACOTHERAPY
- Exenatide extended-release; clinical trials, patient preference, and economic considerations
- (2013) Sheila Doggrell Patient Preference and Adherence
- Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus
- (2013) Chetan Karyekar et al. Clinical Interventions in Aging
- The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2in Spain
- (2013) Tiago Fonseca et al. JOURNAL OF MEDICAL ECONOMICS
- Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment
- (2013) Anja Schweizer et al. Diabetes Therapy
- Treatment of Type 2 Diabetes in the Elderly
- (2012) Medha N. Munshi et al. Current Diabetes Reports
- Metabolic outcomes of elderly patient populations initiating exenatide BID versus insulin glargine in an ambulatory care setting
- (2012) Manjiri Pawaskar et al. CURRENT MEDICAL RESEARCH AND OPINION
- Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation
- (2012) Eberhard Standl et al. Diabetes & Vascular Disease Research
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Diabetes in Older Adults
- (2012) M. S. Kirkman et al. DIABETES CARE
- Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)
- (2012) V. A. Fonseca et al. DIABETES CARE
- Insulin degludec: overview of a novel ultra long-acting basal insulin
- (2012) S. C. L. Gough et al. DIABETES OBESITY & METABOLISM
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes
- (2012) Joel C. Marrs DRUGS & AGING
- A review of the efficacy and safety of oral antidiabetic drugs
- (2012) Stephanie Aleskow Stein et al. Expert Opinion On Drug Safety
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- (2012) JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- FDA rejects novel diabetes drug over safety fears
- (2012) Talha Khan Burki LANCET
- 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
- (2012) Baptist Gallwitz et al. LANCET
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US
- (2012) Yevgeniy Samyshkin et al. JOURNAL OF MEDICAL ECONOMICS
- Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and
- (2011) Bruce W. Bode et al. American Journal Geriatric Pharmacotherapy
- Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control
- (2011) Medha N. Munshi ARCHIVES OF INTERNAL MEDICINE
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Noninsulin Treatment of Type 2 Diabetes Mellitus in Geriatric Patients: A Review
- (2011) F. Wilford Germino CLINICAL THERAPEUTICS
- European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive Summary
- (2011) Alan J. Sinclair et al. DIABETES & METABOLISM
- Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With Diabetes
- (2011) C. G. Lee et al. DIABETES CARE
- Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
- (2011) Y. Handelsman DIABETES CARE
- Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
- (2011) S. Bo et al. DIABETES OBESITY & METABOLISM
- Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence
- (2011) R. E. van Genugten et al. DIABETES OBESITY & METABOLISM
- Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: Yes
- (2011) André J. Scheen European Journal of Internal Medicine
- Income, wealth and risk of diabetes among older adults: cohort study using the English longitudinal study of ageing
- (2011) T. Tanaka et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- The use of insulin in elderly patients with type 2 diabetes mellitus
- (2011) Edoardo Mannucci et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK
- (2011) Amélie Beaudet et al. JOURNAL OF MEDICAL ECONOMICS
- Pharmacologic management of the older patient with type 2 diabetes mellitus
- (2010) Joshua J. Neumiller et al. American Journal Geriatric Pharmacotherapy
- Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus
- (2010) Jessica L Kerr et al. ANNALS OF PHARMACOTHERAPY
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- (2010) J. M. Gaziano et al. DIABETES CARE
- Pharmacoeconomics and Aging
- (2010) Silvia Bustacchini et al. DRUGS & AGING
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
- (2010) David J. Graham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Complexity in Middle-Aged and Older Adults With Diabetes
- (2010) Caroline S. Blaum et al. MEDICAL CARE
- Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
- (2010) Joshua J Neumiller et al. PHARMACOTHERAPY
- Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes
- (2010) Hermes Florez et al. POSTGRADUATE MEDICINE
- Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
- (2009) L. Juurinen et al. DIABETIC MEDICINE
- The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes
- (2009) Hong Li et al. JOURNAL OF BONE AND MINERAL METABOLISM
- A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
- (2009) Daniel H. Solomon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- (2008) Harold E. Bays et al. ARCHIVES OF INTERNAL MEDICINE
- Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-nave elderly patients with type 2 diabetes
- (2007) S. L. Schwarz et al. DIABETES OBESITY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search